Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.40 -1.32% 29.825 185,847 16:35:23
Bid Price Offer Price High Price Low Price Open Price
28.70 30.95 29.55 29.00 29.55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -5.87 -1.83 86
Last Trade Time Trade Type Trade Size Trade Price Currency
16:26:08 O 9,996 29.90 GBX

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Investors    Futura Medical Takeover Rumours

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
01/7/202217:46FUTURA a winner for 201512,408
13/5/202211:57fum revenue-
23/12/202109:25Oh dear....396
23/8/202116:57FUM delivering on sex,pain and rock'n'roll11,721

Add a New Thread

Futura Medical (FUM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 30.23p.
Futura Medical Plc has a 4 week average price of 28.90p and a 12 week average price of 25.95p.
The 1 year high share price is 48.60p while the 1 year low share price is currently 24p.
There are currently 287,296,527 shares in issue and the average daily traded volume is 117,410 shares. The market capitalisation of Futura Medical Plc is £85,686,189.18.
petroc: Poor old LiarBO has completely lost the plot! His problem is that he sold his holding at a huge loss about 5 years ago, and since then has devoted his life to bashing the stock out of revenge, so much so that he's forgotten why the rest of us are here! This board is for people who are invested in AIM, or want to, so they are looking for an exchange of information to try and make some money. LiarBO pretends to be appalled that I'm waiting for the share price to rise so I can sell some or all of my stock at a profit, he's clearly forgotten what investing is all about. He's also forgotten that before he lost all his money by buying and selling FUM shares, he used to post good news about the various holdings he had because he wanted them to do well so he could make some money. (It's all there in his posting history) But then the stupid idiot invested more than he could afford to lose in FUM, expecting CSD500 to do well and make him a fortune, but it didn't and he sold at the bottom of the market. What a prat! The rest is history, and the sad old stock basher just sits in his bedroom, copy/pasting nonsense in an attempt to manipulate the share price downwards so that everyone can lose like he did.
petroc: LiarBO, LiamBooth, Citygirl, and Leveraged should be ashamed of himself, accusing others of having multi-IDs in order to manipulate the share price. 'What Is a Stock Basher? A stock basher is a person engaging in an illegal type of market manipulation to make the price of an asset fall. Stock bashers rely on misinformation campaigns to decrease confidence in a stock, leading to an undervaluation of that stock. In some cases, a stock basher may have a position in the asset which benefits from a fall in price.' hxxps://
lbo: According to Mike who previously said at 34p (£40m market cap) the share price was 'massively overvalued' . So now over 4 years later with still no concrete results in terms of revenue or sales. The company is even more 'massively over valued' at 31p (£90m market Cap)mikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141Company is massively over valued if you go by 'concrete' results !mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections.I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the sharesUnfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 !mikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141FUM are using "a number of advisors specifically working on MED2002/CSD500 as there are several different strategies we are exploring and they have different skill sets."Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he says
j777j: Furthermore,I have been stating for years the selling price will be £5, $5, 5euros a dose and was ridiculed by the paid deramper lbo. Low and behold in the last results the company stated exactly what I had already said Retail price will be £5 $5 5 euros a does. I previously pointed to research by one of the analysts at Singer n+1 stating the manufacturing price will be around 25p per dose. The margin here are going to be absolutely massive and I remain of the conviction that the shares will be trading around 400p a share within the next couple years. Just do the maths yourselves £5 divide 2.3 gives approx wholesale price of £2.17 per dose. Say they only capture a 5% market share of a 200 million men market that is 10 million men. Say they use twice a week,that is £86 million a month to Fum,or £1.04 billion a year.Most of which will go straight through to the bottom line. That with just a 5% market share!!! Absolutely amazing opportunity 10X plus share price potential NO WONDER ONE CO IS IN EXCLUSIVITY TALKS FOR THE WHOLE OF THE EU AND UK Think about it
lbo: Amazing how none of the rampers have made any reference to the fact that ‘No revenue was recognised in the period’ . But weren’t they also ramping the two amazing deals signed with Labatec and M8 in August and September of 2021 when the share price was higher? Yet along come the recent results and no sign of any upfront payments in the Zero revenues? The RNS about the deal with Labatec even said ‘Futura eligible to receive initial upfront payments’. No wonder the share price is lower then where it was after all their ramping has been proven to be false. Petroc even said he should be sued if the FACTS he posted were not true! Oh dear indeed! petroc - 04 Mar 2022 - 17:32:56 - 10795 of 11563 What is not to love ‘Eroxon /MED3000 - HERE ARE THE FACTS I can personally vouch for everything I said above to be true. If it isn't, sue me.
lbo: ‘I would imagine they will line up a buyer and flog their stake for massive profits’. When did we hear that before? The old Reckitt rumour that preceded the massive share price crash as they walked away from Futura. I agree. They would sell if they could find a buyer and since their average share price is well below the current share price. They could still sell out well below the current share price and still make ‘massive profits’ while all the other shareholders make massive losses. The question is who would want to buy a cooling lubricant of highly questionable efficacy and even more questionable patent? All the other products too have failed or gone into limbo with their patents expiring But maybe the beneficial owners of the shares in those Swiss DISCRETIONARY accounts can pull off the sale of the century and sell nothing for something to someone else! ‘Former insurance broker James Barder became involved with Futura having made an investment in what was a private company; pre-Viagra, he, some family and friends all thought it a 'bit of a laugh' initially, but are now very serious. Together they speak for around 25% of the company and many of them came in at the equivalent of 1p a share’
j777j: So we know Viagra can leave you dead or blind and will likely have to change the warnings on the label. Fum results likely to have been moved around as they already told us they are busy working on deals closer to home (EU/UK) So expecting RNS anytime now We also know the read outs from the US trial should be coming into the company in real time give them valuable information. We also know there were a significant amount ( 8 to 10 million)of shares that had been lent out to shorters. They may want to close before the news starts arriving. I suspect the share price will have a very strong period of recovery back up towards the 80's. Av price target is appox 92p from two analysts. PS I also note that since the last time I posted,the paid deramper workign for Pfizer or others has continued to spam the board 24/7
lbo: ‘I cannot see any other reason for a delay’ What about another dilutive fundraising below the price of the last one to try raise more money to go it alone with Eroxon aka the plan as no real distributors have any interest in paying any real money licensing it or spending millions on trying to market a placebo of questionable efficacy. ‘the immediate potential for substantial royalties is low in the absence of a large global brand 'carrier' to take the product forward’ Would explain why some institutions are seemingly running for the exit as quick as they can. Problem will be Lombard won’t be able to really support any more fundraising’s now without risking going over 30%. But if they also hadn’t supported the share price and bought all the recent shares sold then the share price would also have collapsed back to 7p/8p that they previously a lot of their shares at when no partner was willing to pony up for MED2002/2005 before it failed at Phase 3
j777j: The bottom line is Fum will be making something like 192p per unit from a cost price of 25p Also remember all marketing costs will be borne by the licensing partner. So say 10 million men market share out of 200 million men Use twice a week at wholesale price to Fum 217p per unit. Cost per unit 25p That brings £38 million a week to FUM pretty much straight through to the bottom line for reasons giving above. Multi pound share price possible here.Furthermore we know many patients results will soon be flooding into Fum as the fist patients started enrollment sept 20 last year and from start to finish Fum stated 7 months
j777j: Big news on the way.The co clearly in final negotations for the EU and UK launches The FDA study will be producing results in real time for the co too. We know the first patient was enrolled in the six month study back in september and that by dec 20th all 100 had been enrolled. "On 14 September 2021 the first patient was enrolled in the FM71 confirmatory clinical study." All coming into place and I suspect the share price will start rallying ahead of all that. Current price target average is around 92p compared to current share price of 25P LBO is a paid deramper probably by one of the large pharams that are terrified to see their often deadly viagra and cialis drugs market share evaporate overnnight as sensible men choose a topically applied alternative with no dangerous side effects 10% market share of a 200 million men market pace at £5 per dose is £100million revenues a week if they only use one time a week. Th fact remains that 10 percent up to 20 percent of men are contraindicated to viagra and cialies due to existing medications.. So in effect a shoe in for Fum This share has clear potential to go well into the pounds a share.Just do the figures History reveals the share price is able to double or treble in a matter of days.
Futura Medical share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 16:54:43